Cash Flow from Operating Activities: A company's cash flows from operations.
Citius Pharmaceuticals, Inc. (CTXR) had Cash Flow from Operating Activities of $-26.55M for the most recently reported fiscal year, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-37.43M |
|
-- |
|
-- |
|
$38.53M |
|
$-38.53M |
|
$-0.16M |
|
$-38.68M |
|
$-38.68M |
|
$-39.74M |
|
$-39.74M |
|
$-39.74M |
|
$-39.74M |
|
$-38.53M |
|
$-38.31M |
|
11.07M |
|
11.07M |
|
$-3.38 |
|
$-3.38 |
|
| Balance Sheet Financials | |
$27.93M |
|
-- |
|
$103.00M |
|
$130.94M |
|
$44.91M |
|
-- |
|
$8.50M |
|
$53.41M |
|
$77.53M |
|
$68.18M |
|
$77.53M |
|
18.07M |
|
| Cash Flow Statement Financials | |
|
Cash Flow from Operating Activities |
$-26.55M |
$-5.75M |
|
$33.30M |
|
$3.25M |
|
$4.25M |
|
$1.00M |
|
$10.84M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.62 |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-26.55M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-51.26% |
|
-58.29% |
|
-30.35% |
|
-51.26% |
|
$4.29 |
|
$-2.40 |
|
$-2.40 |
|